Skip to main content

SNDL Inc.

SNDL
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001766600

No open-market purchases or sales by SNDL Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding SNDL Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of SNDL: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders1002100+2
Shares9.95M1.54K13.0M+3.08M (+31.0%)
Value$13.6M$2.11K$24.7M+$11.1M (+81.4%)

2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held SNDL Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to SNDL in Q3 2023
InstitutionSharesValue% of portfolio
Virtu Financial LLC217,860$414.0K0.04%
Two Sigma Advisers, LP33,400$63.5K0.00%
Capital Advisors Inc13,517$25.7K0.00%
HighTower Advisors, LLC10,698$21.0K0.00%
Naples Global Advisors, LLC10,000$19.0K0.00%
Toronto Dominion Bank5,189$9.86K0.00%
Bull Oak Capital, LLC500$9500.00%
BlackRock Inc.350$6650.00%
FMR LLC100$1900.00%
Baldwin Brothers Inc50$950.00%
Addison Advisors LLC20$380.00%
NBC Securities, Inc.37$00.00%
Desjardins Global Asset Management Inc.13,339––

Sold out (11)

Institutions that held SNDL Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (2)

Institutions that held SNDL Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SNDL in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
First Capital Advisors Group, LLC.1,287$1.76K
Piershale Financial Group, Inc.254$348